Information Request Form

Section:	Main.EAR NOSE THROAT (ENT).Tumor Necrosis Factor AntAgonist.MAb Type TNF AntAgonist..Etanercept; InflixiMAb Etc..Immune Cochlear Vestibular Disorde.Patent..Claims.Claim 1: Immune Ear Disorder Treat.Adm. TNF AntAgonist. Claim 3:.Immune CochlearVestibular Disorder.Claim 4: Hearing Impairment. Claim.5: AutoImmune-Mediated. Claim 6:.Affects Inner Ear. Claim 9: TNF.AntAgonist: Etanercept. Claim 10:.TNF AntAgonist: InflixiMAb. Claim.11: CoAdm Pyrimidine Synthesis Inhi.bitor (PSI) or Anti-Rheumatic Ag.(ARA). Claim 12: PSI: Leflunomide.Claim 13: ARA: Methotrexate..Patent Assignee
Code:	59828
Product:	USA. G
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER PATENT PARENT CASE TEXT
* If you are not linked to any company or organization complete at least this field